Insider Transactions in Q1 2022 at Windtree Therapeutics Inc (WINT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2022
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.94%
|
$0
$0.98 P/Share
|
|
Mar 15
2022
|
Craig Fraser President and CEO |
BUY
Open market or private purchase
|
Direct |
3,000
+1.42%
|
$0
$0.98 P/Share
|
|
Mar 15
2022
|
Steven Simonson SVP, Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+5.64%
|
$5,000
$1.0 P/Share
|
|
Mar 04
2022
|
Diane Carman SVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
66,300
+50.0%
|
-
|
|
Mar 04
2022
|
Eric Curtis SVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
66,300
+49.52%
|
-
|
|
Mar 04
2022
|
Craig Fraser President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
166,900
+44.87%
|
-
|
|
Mar 04
2022
|
John P. Hamill SVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
66,300
+48.71%
|
-
|
|
Mar 04
2022
|
Steven Simonson SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,300
+45.76%
|
-
|